Ieramilimab
Ieramilimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Ieramilimab is under investigation in clinical trial NCT02460224 (Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.).
| Trade Name | Ieramilimab |
| Generic | Ieramilimab |
| Ieramilimab Other Names | Ieramilimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ieramilimab
